首页 > 最新文献

Journal of negative results in biomedicine最新文献

英文 中文
Case-control association between CCT-associated variants and keratoconus in a Saudi Arabian population. 沙特阿拉伯人群中 CCT 相关变异与角膜炎之间的病例对照关联。
Pub Date : 2015-06-04 DOI: 10.1186/s12952-015-0029-5
Khaled K Abu-Amero, Inas Helwa, Abdulrahman Al-Muammar, Shelby Strickland, Michael A Hauser, R Rand Allingham, Yutao Liu

Background: Keratoconus (KC) is the most common primary ectatic disease of the cornea and a major indication for corneal transplant. To date, limited KC-associated-risk loci have been identified. Association has recently been suggested between KC and 8 single nucleotide polymorphisms (SNPs) in the genomic regions of FNDC3B, COL4A3, MPDZ-NF1B, RXRA-COL5A1, LCN12-PTGDS, FOXO1, and BANP-ZNF469. These SNPs are associated with central corneal thickness (CCT), a known risk factor to KC. We are questioning whether these SNPs are significantly associated with KC in a Saudi Arabian population. The study included 108 unrelated KC cases and 300 controls. Patients were diagnosed with KC according to the Schimpff-flow based elevation map of the cornea. DNA genotyping was done using probe-based allelic discrimination TaqMan assays. Allele frequencies were compared between the cases and controls.

Results: All SNPs were successfully genotyped with high efficiency (>95 %). The SNPs had no significant deviation in cases or controls from Hardy-Weinberg Equilibrium (HWE, p value > 0.05). None of the selected SNPs were significantly associated with KC in the Saudi Arabian population. However, we replicated the same trend of minor allele frequency (MAF) between cases and controls reported by a recent GWAS regarding the 5 SNPs rs4894535 (FNDC3B, chr3: 171995605), rs1536482 (RXRA-COL5A1, chr9: 137440528), rs7044529 (COL5A1, chr9: 137568051), rs11145951 (LCN12-PTGDS, chr9: 139860264), and rs2721051 (FOXO1, chr13: 41110884).

Conclusions: This is the first study investigating the association of these SNPs with KC in a population from Saudi Arabia. We replicated the same trend of MAF alteration of the association between the SNPs rs4894535 (FNDC3B, chr3: 171995605), rs7044529 (COL5A1, chr9: 137568051), rs11145951 (LCN12-PTGDS, chr9: 139860264) and rs2721051 (FOXO1, chr13: 41110884) and KC-risk as reported by a recently published GWAS. Consistently replicated population-based studies are necessary to identify and/or confirm genetic susceptibility for certain diseases. We acknowledge that the lack of significance in our study is due to our small sample size and insufficient statistical power; however our data still add to the body of evidence of potential KC-candidate SNPs. This report aims at supporting the possible association between CCT-associated SNPs and KC susceptibility.

背景:角膜炎(KC)是最常见的原发性角膜异位疾病,也是角膜移植的主要适应症。迄今为止,与 KC 相关的风险基因位点还很有限。最近有研究表明,KC 与 FNDC3B、COL4A3、MPDZ-NF1B、RXRA-COL5A1、LCN12-PTGDS、FOXO1 和 BANP-ZNF469 基因组区域中的 8 个单核苷酸多态性(SNPs)有关。这些 SNP 与角膜中央厚度 (CCT) 相关,而 CCT 是已知的 KC 风险因素。我们的问题是,在沙特阿拉伯人群中,这些 SNPs 是否与 KC 显著相关。这项研究包括 108 例无关的 KC 病例和 300 例对照。根据基于 Schimpff 流量的角膜升高图诊断患者为 KC。使用基于探针的等位基因鉴别 TaqMan 检测法进行 DNA 基因分型。比较了病例和对照组的等位基因频率:结果:所有 SNP 都成功地进行了基因分型,且效率很高(>95%)。病例和对照组中的 SNPs 均未明显偏离 Hardy-Weinberg Equilibrium(HWE,p 值 > 0.05)。在沙特阿拉伯人群中,所选 SNPs 均与 KC 无关。然而,我们复制了最近一项全球基因组研究中报告的病例与对照之间小等位基因频率(MAF)的相同趋势,即 5 个 SNPs rs4894535(FNDC3B,chr3:171995605)、rs1536482(RXRA-COL5A1,chr9:137440528)、rs7044529(COL5A1,chr9:137568051)、rs11145951(LCN12-PTGDS,chr9:139860264)和 rs2721051(FOXO1,chr13:41110884)。结论这是第一项在沙特阿拉伯人群中调查这些 SNP 与 KC 关联性的研究。我们复制了最近发表的一项 GWAS 报告中提到的 SNPs rs4894535(FNDC3B,chr3: 171995605)、rs7044529(COL5A1,chr9: 137568051)、rs11145951(LCN12-PTGDS,chr9: 139860264)和 rs2721051(FOXO1,chr13: 41110884)与 KC 风险之间关联的 MAF 改变趋势。要识别和/或确认某些疾病的遗传易感性,就必须进行基于人群的持续重复研究。我们承认,我们的研究缺乏显著性是由于样本量较小和统计能力不足造成的;但是,我们的数据仍然为潜在的 KC 候选 SNP 增添了证据。本报告旨在支持 CCT 相关 SNP 与 KC 易感性之间可能存在的关联。
{"title":"Case-control association between CCT-associated variants and keratoconus in a Saudi Arabian population.","authors":"Khaled K Abu-Amero, Inas Helwa, Abdulrahman Al-Muammar, Shelby Strickland, Michael A Hauser, R Rand Allingham, Yutao Liu","doi":"10.1186/s12952-015-0029-5","DOIUrl":"10.1186/s12952-015-0029-5","url":null,"abstract":"<p><strong>Background: </strong>Keratoconus (KC) is the most common primary ectatic disease of the cornea and a major indication for corneal transplant. To date, limited KC-associated-risk loci have been identified. Association has recently been suggested between KC and 8 single nucleotide polymorphisms (SNPs) in the genomic regions of FNDC3B, COL4A3, MPDZ-NF1B, RXRA-COL5A1, LCN12-PTGDS, FOXO1, and BANP-ZNF469. These SNPs are associated with central corneal thickness (CCT), a known risk factor to KC. We are questioning whether these SNPs are significantly associated with KC in a Saudi Arabian population. The study included 108 unrelated KC cases and 300 controls. Patients were diagnosed with KC according to the Schimpff-flow based elevation map of the cornea. DNA genotyping was done using probe-based allelic discrimination TaqMan assays. Allele frequencies were compared between the cases and controls.</p><p><strong>Results: </strong>All SNPs were successfully genotyped with high efficiency (>95 %). The SNPs had no significant deviation in cases or controls from Hardy-Weinberg Equilibrium (HWE, p value > 0.05). None of the selected SNPs were significantly associated with KC in the Saudi Arabian population. However, we replicated the same trend of minor allele frequency (MAF) between cases and controls reported by a recent GWAS regarding the 5 SNPs rs4894535 (FNDC3B, chr3: 171995605), rs1536482 (RXRA-COL5A1, chr9: 137440528), rs7044529 (COL5A1, chr9: 137568051), rs11145951 (LCN12-PTGDS, chr9: 139860264), and rs2721051 (FOXO1, chr13: 41110884).</p><p><strong>Conclusions: </strong>This is the first study investigating the association of these SNPs with KC in a population from Saudi Arabia. We replicated the same trend of MAF alteration of the association between the SNPs rs4894535 (FNDC3B, chr3: 171995605), rs7044529 (COL5A1, chr9: 137568051), rs11145951 (LCN12-PTGDS, chr9: 139860264) and rs2721051 (FOXO1, chr13: 41110884) and KC-risk as reported by a recently published GWAS. Consistently replicated population-based studies are necessary to identify and/or confirm genetic susceptibility for certain diseases. We acknowledge that the lack of significance in our study is due to our small sample size and insufficient statistical power; however our data still add to the body of evidence of potential KC-candidate SNPs. This report aims at supporting the possible association between CCT-associated SNPs and KC susceptibility.</p>","PeriodicalId":73849,"journal":{"name":"Journal of negative results in biomedicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461978/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33357039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative endoscopic tattooing to mark the tumour site does not improve lymph node retrieval in colorectal cancer: a retrospective cohort study. 术前内镜纹身标记肿瘤部位并不能提高结直肠癌淋巴结取材率:一项回顾性队列研究。
Pub Date : 2015-05-07 DOI: 10.1186/s12952-015-0027-7
Carlo V Feo, Mattia Portinari, Michele Zuolo, Simone Targa, Vincenzo G Matarese, Roberta Gafà, Elena Forini, Giovanni Lanza

Background: A direct correlation between number of lymph nodes retrieved and evaluated after a colectomy for colorectal cancer and survival of the patient has been reported, and consensus guidelines recommend to assess at least 12 lymph nodes for adequate staging. Many factors (i.e., patients' and tumour characteristics, surgeon, and pathologist) may influence the evaluation of the presence of neoplastic disease in lymph nodes as well as the total number of lymph nodes examined. Preoperative endoscopic tattooing to mark the site of the tumour has recently been suggested to facilitate the retrieval of lymph nodes in colorectal specimens. The aim of this study was to investigate its association with adequate lymphadenectomy (≥12 nodes) after colorectal resection for cancer.

Results: All patients undergoing elective colorectal resection for cancer between 2009 and 2011 at the S. Anna University Hospital in Ferrara, Italy (N = 250) were retrospectively divided into two cohorts according to whether ink tattooing to mark the tumour site was performed during preoperative colonoscopy. The two cohorts were comparable regarding age, gender, body mass index, tumour location and size, TNM staging, and DNA microsatellite instability-high status. No difference between the tattoo (N = 107) and control (N = 143) groups could be detected in the rate of adequate lymphadenectomies performed (78% vs. 79%, p = 0.40). All factors known to influence lymph nodes retrieval from colorectal specimen were specifically evaluated. Rectal and colonic cancers were analysed together and separately. Full adjusted logistic regression analysis in patients who underwent colonic resection showed that right hemicolectomy (OR 4.72; CI95% 1.09-20.36) was the only factor associated to adequate lymphadenectomy. No association between ink tattooing performed preoperatively to mark the site of the tumour and adequate lymphadenectomy after colorectal resection was found with logistic regression analysis.

Conclusion: This study shows that preoperative ink tattooing utilized to mark the site of the tumour does not improve adequate lymphadenectomy and lymph nodes yield from colorectal cancer specimens. Further studies are therefore needed to determine if preoperative colonoscopic tattooing to mark the tumour site can refine staging.

背景:有报道称,结直肠癌结肠切除术后取回和评估的淋巴结数量与患者的存活率直接相关,共识指南建议至少评估 12 个淋巴结以进行充分分期。许多因素(如患者和肿瘤特征、外科医生和病理学家)都可能影响对淋巴结是否存在肿瘤性疾病的评估以及检查的淋巴结总数。最近有人建议术前在内镜上刺青标记肿瘤部位,以方便取回结直肠标本中的淋巴结。本研究的目的是调查其与结直肠癌切除术后淋巴结充分切除(≥12个)的关系:根据术前结肠镜检查时是否对肿瘤部位进行纹身标记,将 2009 年至 2011 年期间在意大利费拉拉 S. Anna 大学医院接受选择性结肠直肠癌切除术的所有患者(250 人)回顾性地分为两个队列。两组患者的年龄、性别、体重指数、肿瘤位置和大小、TNM分期和DNA微卫星不稳定性高的情况相当。纹身组(107 人)和对照组(143 人)在淋巴结切除率方面没有差异(78% 对 79%,P=0.40)。对所有已知的影响大肠标本淋巴结取材的因素进行了专门评估。对直肠癌和结肠癌进行了综合分析和单独分析。对接受结肠切除术的患者进行的全面调整逻辑回归分析表明,右半结肠切除术(OR 4.72;CI95% 1.09-20.36)是唯一与淋巴结充分切除相关的因素。通过逻辑回归分析发现,术前为标记肿瘤部位而进行的墨水纹身与结肠直肠切除术后淋巴结的充分切除之间没有关联:本研究表明,术前利用纹身标记肿瘤部位并不能提高淋巴结切除率和大肠癌标本的淋巴结产量。因此,需要进一步研究确定术前结肠镜纹身标记肿瘤部位是否能完善分期。
{"title":"Preoperative endoscopic tattooing to mark the tumour site does not improve lymph node retrieval in colorectal cancer: a retrospective cohort study.","authors":"Carlo V Feo, Mattia Portinari, Michele Zuolo, Simone Targa, Vincenzo G Matarese, Roberta Gafà, Elena Forini, Giovanni Lanza","doi":"10.1186/s12952-015-0027-7","DOIUrl":"10.1186/s12952-015-0027-7","url":null,"abstract":"<p><strong>Background: </strong>A direct correlation between number of lymph nodes retrieved and evaluated after a colectomy for colorectal cancer and survival of the patient has been reported, and consensus guidelines recommend to assess at least 12 lymph nodes for adequate staging. Many factors (i.e., patients' and tumour characteristics, surgeon, and pathologist) may influence the evaluation of the presence of neoplastic disease in lymph nodes as well as the total number of lymph nodes examined. Preoperative endoscopic tattooing to mark the site of the tumour has recently been suggested to facilitate the retrieval of lymph nodes in colorectal specimens. The aim of this study was to investigate its association with adequate lymphadenectomy (≥12 nodes) after colorectal resection for cancer.</p><p><strong>Results: </strong>All patients undergoing elective colorectal resection for cancer between 2009 and 2011 at the S. Anna University Hospital in Ferrara, Italy (N = 250) were retrospectively divided into two cohorts according to whether ink tattooing to mark the tumour site was performed during preoperative colonoscopy. The two cohorts were comparable regarding age, gender, body mass index, tumour location and size, TNM staging, and DNA microsatellite instability-high status. No difference between the tattoo (N = 107) and control (N = 143) groups could be detected in the rate of adequate lymphadenectomies performed (78% vs. 79%, p = 0.40). All factors known to influence lymph nodes retrieval from colorectal specimen were specifically evaluated. Rectal and colonic cancers were analysed together and separately. Full adjusted logistic regression analysis in patients who underwent colonic resection showed that right hemicolectomy (OR 4.72; CI95% 1.09-20.36) was the only factor associated to adequate lymphadenectomy. No association between ink tattooing performed preoperatively to mark the site of the tumour and adequate lymphadenectomy after colorectal resection was found with logistic regression analysis.</p><p><strong>Conclusion: </strong>This study shows that preoperative ink tattooing utilized to mark the site of the tumour does not improve adequate lymphadenectomy and lymph nodes yield from colorectal cancer specimens. Further studies are therefore needed to determine if preoperative colonoscopic tattooing to mark the tumour site can refine staging.</p>","PeriodicalId":73849,"journal":{"name":"Journal of negative results in biomedicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33279232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Waiting time and the psychosocial consequences of false-positive mammography: cohort study. 乳房 X 射线照相术假阳性的等待时间和社会心理后果:队列研究。
Pub Date : 2015-04-30 DOI: 10.1186/s12952-015-0028-6
Bruno Heleno, Volkert Siersma, John Brodersen

Background: There is wide variation in the psychosocial response to false-positive mammography. We aimed to assess whether women having to wait longer to exclude cancer had increased psychosocial consequences that persisted after cancer was ruled out.

Findings: We selected women with false-positive mammography (n = 272), screened for breast cancer in Copenhagen and Funen (Denmark) over a 1-year period. We measured psychosocial consequences immediately before women attended their recall visit and 1, 6, 18 and 36 months after women received their final diagnosis. After women were told that cancer had been ruled out, adverse psychosocial consequences decreased with time. We found no statistically significant differences between women who had cancer ruled out immediately at the recall visit (waiting time of 0) and women who had to wait longer before cancer was ruled out (waiting times 1-30, 30-120 and > 120 days), when psychosocial consequences were measured via a condition-specific questionnaire (Consequences of Screening in Breast Cancer) at 5 time points (0, 1, 6, 18 and 36 months after cancer exclusion).

Conclusion: We did not confirm that waiting time was associated with worse long-term psychosocial consequences but type II error (failure to detect a true difference) might be a plausible explanation for our results.

背景:乳房 X 射线检查假阳性的社会心理反应差异很大。我们的目的是评估妇女需要等待更长时间才能排除癌症是否会增加社会心理后果,这种后果在排除癌症后是否会持续存在:我们选取了在哥本哈根和富能(丹麦)接受为期一年的乳腺癌筛查的乳腺 X 射线假阳性妇女(n = 272)。我们在妇女接受回访前以及接受最终诊断后的 1、6、18 和 36 个月测量了她们的社会心理后果。在妇女被告知癌症已被排除后,不良的社会心理后果随着时间的推移而减少。我们发现,在 5 个时间点(癌症排除后的 0、1、6、18 和 36 个月)通过特定情况问卷(乳腺癌筛查后果)测量社会心理后果时,在复诊时立即排除癌症的妇女(等待时间为 0)和需要等待更长时间才能排除癌症的妇女(等待时间为 1-30、30-120 和大于 120 天)之间没有统计学意义上的显著差异:我们没有证实等待时间与较差的长期社会心理后果有关,但II型误差(未能检测到真正的差异)可能是我们的结果的一个合理解释。
{"title":"Waiting time and the psychosocial consequences of false-positive mammography: cohort study.","authors":"Bruno Heleno, Volkert Siersma, John Brodersen","doi":"10.1186/s12952-015-0028-6","DOIUrl":"10.1186/s12952-015-0028-6","url":null,"abstract":"<p><strong>Background: </strong>There is wide variation in the psychosocial response to false-positive mammography. We aimed to assess whether women having to wait longer to exclude cancer had increased psychosocial consequences that persisted after cancer was ruled out.</p><p><strong>Findings: </strong>We selected women with false-positive mammography (n = 272), screened for breast cancer in Copenhagen and Funen (Denmark) over a 1-year period. We measured psychosocial consequences immediately before women attended their recall visit and 1, 6, 18 and 36 months after women received their final diagnosis. After women were told that cancer had been ruled out, adverse psychosocial consequences decreased with time. We found no statistically significant differences between women who had cancer ruled out immediately at the recall visit (waiting time of 0) and women who had to wait longer before cancer was ruled out (waiting times 1-30, 30-120 and > 120 days), when psychosocial consequences were measured via a condition-specific questionnaire (Consequences of Screening in Breast Cancer) at 5 time points (0, 1, 6, 18 and 36 months after cancer exclusion).</p><p><strong>Conclusion: </strong>We did not confirm that waiting time was associated with worse long-term psychosocial consequences but type II error (failure to detect a true difference) might be a plausible explanation for our results.</p>","PeriodicalId":73849,"journal":{"name":"Journal of negative results in biomedicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423128/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33260602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No association of apolipoprotein B gene polymorphism and blood lipids in obese Egyptian subjects. 埃及肥胖者的载脂蛋白 B 基因多态性与血脂没有关联。
Pub Date : 2015-03-18 DOI: 10.1186/s12952-015-0026-8
Neda M Bogari, Azza M Abdel-Latif, Maha A Hassan, Abeer Ramadan, Ahmed Fawzy

Background: Several environmental and genetic factors are associated with high levels of lipids in obese patients. Apolipoprotein B (ApoB) is the major protein component of low-density lipoproteins (LDL), very-low density lipoproteins (VLDL) and chylomicrons and plays a central role in lipid metabolism. Several apoB restriction fragment length polymorphisms (XbaI, EcoRI, MspI) have been reported to be associated with variation in lipid levels and obesity. To date, no data are available on the relationship between XbaI polymorphism and lipid levels in Egyptian populations. Following clinical profiling, 178 obese (body mass index [BMI] >25 kg/m(2)) and 178 age-matched non-obese (BMI ≤ 25 kg/m(2)) subjects were included in this case-control study. All samples were analysed for total cholesterol, triglycerides and HDL-cholesterol. Genetic analysis of apoB XbaI (X) was performed using Polymerase Chain Reaction-Restriction Fragment Length polymorphism (PCR-RFLP). The aim of this study was to assess the association of apoB XbaI gene polymorphism (X) and lipid profiles in obese and non-obese Egyptian populations.

Results: Obese subjects demonstrated significantly higher values of waist-to-hip ratio, blood pressure, and total lipid. However, in our sample we did not find significant differences in apoB XbaI gene polymorphism (X) genotype or allele frequencies. Moreover, none of the studied lipid parameters showed any association with the gene polymorphism.

Conclusion: This study reveals no significant association of apoB XbaI gene polymorphism (X) with obesity or lipid profiles in an Egyptian population.

背景:肥胖患者的高血脂与多种环境和遗传因素有关。载脂蛋白 B(ApoB)是低密度脂蛋白(LDL)、极低密度脂蛋白(VLDL)和乳糜微粒的主要蛋白质成分,在脂质代谢中起着核心作用。据报道,多种载脂蛋白限制性片段长度多态性(XbaI、EcoRI、MspI)与血脂水平变化和肥胖有关。迄今为止,还没有关于埃及人群中 XbaI 多态性与血脂水平之间关系的数据。经过临床分析,178 名肥胖者(体重指数 [BMI] >25 kg/m(2))和 178 名年龄匹配的非肥胖者(体重指数 ≤ 25 kg/m(2))被纳入了这项病例对照研究。对所有样本进行了总胆固醇、甘油三酯和高密度脂蛋白胆固醇分析。利用聚合酶链式反应-限制性片段长度多态性(PCR-RFLP)对载脂蛋白B XbaI (X)进行了遗传分析。本研究的目的是评估埃及肥胖和非肥胖人群中载脂蛋白B XbaI基因多态性(X)与血脂谱的关系:结果:肥胖受试者的腰臀比、血压和总血脂值明显较高。然而,在我们的样本中,我们没有发现载脂蛋白B XbaI基因多态性(X)基因型或等位基因频率的显著差异。此外,所研究的血脂参数均未显示与基因多态性有任何关联:本研究表明,在埃及人群中,apoB XbaI 基因多态性 (X) 与肥胖或血脂特征没有明显的关联。
{"title":"No association of apolipoprotein B gene polymorphism and blood lipids in obese Egyptian subjects.","authors":"Neda M Bogari, Azza M Abdel-Latif, Maha A Hassan, Abeer Ramadan, Ahmed Fawzy","doi":"10.1186/s12952-015-0026-8","DOIUrl":"10.1186/s12952-015-0026-8","url":null,"abstract":"<p><strong>Background: </strong>Several environmental and genetic factors are associated with high levels of lipids in obese patients. Apolipoprotein B (ApoB) is the major protein component of low-density lipoproteins (LDL), very-low density lipoproteins (VLDL) and chylomicrons and plays a central role in lipid metabolism. Several apoB restriction fragment length polymorphisms (XbaI, EcoRI, MspI) have been reported to be associated with variation in lipid levels and obesity. To date, no data are available on the relationship between XbaI polymorphism and lipid levels in Egyptian populations. Following clinical profiling, 178 obese (body mass index [BMI] >25 kg/m(2)) and 178 age-matched non-obese (BMI ≤ 25 kg/m(2)) subjects were included in this case-control study. All samples were analysed for total cholesterol, triglycerides and HDL-cholesterol. Genetic analysis of apoB XbaI (X) was performed using Polymerase Chain Reaction-Restriction Fragment Length polymorphism (PCR-RFLP). The aim of this study was to assess the association of apoB XbaI gene polymorphism (X) and lipid profiles in obese and non-obese Egyptian populations.</p><p><strong>Results: </strong>Obese subjects demonstrated significantly higher values of waist-to-hip ratio, blood pressure, and total lipid. However, in our sample we did not find significant differences in apoB XbaI gene polymorphism (X) genotype or allele frequencies. Moreover, none of the studied lipid parameters showed any association with the gene polymorphism.</p><p><strong>Conclusion: </strong>This study reveals no significant association of apoB XbaI gene polymorphism (X) with obesity or lipid profiles in an Egyptian population.</p>","PeriodicalId":73849,"journal":{"name":"Journal of negative results in biomedicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389411/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33232226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thanks to all those who reviewed for Journal of Negative Results in Biomedicine in 2014 感谢所有2014年Journal of Negative Results in biomedine的审稿人
Pub Date : 2015-03-06 DOI: 10.1186/s12952-015-0025-9
B. Olsen, B. Brachvogel
{"title":"Thanks to all those who reviewed for Journal of Negative Results in Biomedicine in 2014","authors":"B. Olsen, B. Brachvogel","doi":"10.1186/s12952-015-0025-9","DOIUrl":"https://doi.org/10.1186/s12952-015-0025-9","url":null,"abstract":"","PeriodicalId":73849,"journal":{"name":"Journal of negative results in biomedicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12952-015-0025-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65694595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No effects of a 12-week supervised exercise therapy program on gait in patients with mild to moderate osteoarthritis: a secondary analysis of a randomized trial. 一项随机试验的二次分析:12周的监督运动治疗计划对轻度至中度骨关节炎患者的步态没有影响。
Pub Date : 2015-03-05 DOI: 10.1186/s12952-015-0023-y
Ingrid Eitzen, Linda Fernandes, Lars Nordsletten, May Arna Risberg

Background: It is unknown whether gait biomechanics in hip osteoarthritis patients with mild to moderate symptoms change following exercise therapy interventions. The aim of the present study was to compare stance phase gait characteristics in hip osteoarthritis patients with mild to moderate symptoms participating in a randomized trial with two different interventions; patient education only or patient education followed by a 12-week supervised exercise therapy program.

Results: The study was conducted as a secondary analysis of a single-blinded randomized controlled trial. Patients aged 40 to 80 years, with hip osteoarthritis verified from self-reported pain and radiographic changes, were included. The final material comprised 23 patients (10 males/13 females, mean (SD) age 58.2 (10.02) years) in the patient education only group, and 22 patients (9 males/13 females, mean (SD) age 60.2 (9.49) years) in the patient education + exercise therapy group. Three-dimensional gait analysis was conducted at baseline and at four month follow-up. Sagittal and frontal plane joint angle displacement and external joint moments of the hip, knee and ankle were compared from a one-way analysis of covariance between the groups at follow-up, with baseline values as covariates (p < 0.05). No group differences were observed at the four-month follow-up in gait velocity, joint angle displacement, or moments. As the compliance in the exercise therapy group was inadequate, we calculated possible associations between the number of completed exercise sessions and change in each of the kinematic or kinetic variables. Associations were weak to neglible. Thus, the negative findings in this study cannot be explained from inadequate compliance alone, but most likely also suggest the exercise therapy program itself to be insufficient to engender gait alterations.

Conclusions: Adding a 12-week supervised exercise therapy program to patient education did not induce changes in our selected biomechanical variables during the stance phase of gait, even when adjusting for poor compliance. Thus, we did not find evidence to support our exercise therapy program to be an efficacious intervention to induce gait alterations in this population of hip osteoarthritis patients.

Trial registration: NCT00319423 at ClinicalTrials.gov (registration date 2006-04-26).

背景:目前尚不清楚轻度至中度症状的髋关节骨关节炎患者的步态生物力学是否会在运动治疗干预后发生变化。本研究的目的是比较参加两种不同干预措施的轻度至中度症状髋关节骨关节炎患者的站立阶段步态特征;仅对患者进行教育或对患者进行教育后进行为期12周的有监督的运动治疗计划。结果:本研究为单盲随机对照试验的二次分析。年龄在40 - 80岁之间,通过自我报告的疼痛和影像学改变证实患有髋关节骨关节炎的患者被纳入研究。最终材料包括患者教育组23例患者(10男13女,平均(SD)年龄58.2(10.02)岁),患者教育+运动治疗组22例患者(9男13女,平均(SD)年龄60.2(9.49)岁)。在基线和4个月随访时进行三维步态分析。随访时,采用单因素协方差分析比较两组间髋、膝、踝关节矢、额面关节角度位移和关节外力矩,协变量为基线值(p < 0.05)。在四个月的随访中,在步态速度、关节角度位移或力矩方面没有观察到组间差异。由于运动治疗组的依从性不足,我们计算了完成运动次数与每个运动学或动力学变量变化之间可能存在的关联。这种关联弱到可以忽略不计。因此,这项研究的负面结果不能仅仅从依从性不足来解释,而很可能也表明运动治疗方案本身不足以产生步态改变。结论:在患者教育中加入为期12周的有监督的运动治疗计划,并没有引起我们选择的步态站立阶段的生物力学变量的变化,即使在调整依从性较差时也是如此。因此,我们没有发现证据支持我们的运动治疗方案是一种有效的干预措施,以诱导这类髋关节骨关节炎患者的步态改变。试验注册:NCT00319423, ClinicalTrials.gov(注册日期2006-04-26)。
{"title":"No effects of a 12-week supervised exercise therapy program on gait in patients with mild to moderate osteoarthritis: a secondary analysis of a randomized trial.","authors":"Ingrid Eitzen,&nbsp;Linda Fernandes,&nbsp;Lars Nordsletten,&nbsp;May Arna Risberg","doi":"10.1186/s12952-015-0023-y","DOIUrl":"https://doi.org/10.1186/s12952-015-0023-y","url":null,"abstract":"<p><strong>Background: </strong>It is unknown whether gait biomechanics in hip osteoarthritis patients with mild to moderate symptoms change following exercise therapy interventions. The aim of the present study was to compare stance phase gait characteristics in hip osteoarthritis patients with mild to moderate symptoms participating in a randomized trial with two different interventions; patient education only or patient education followed by a 12-week supervised exercise therapy program.</p><p><strong>Results: </strong>The study was conducted as a secondary analysis of a single-blinded randomized controlled trial. Patients aged 40 to 80 years, with hip osteoarthritis verified from self-reported pain and radiographic changes, were included. The final material comprised 23 patients (10 males/13 females, mean (SD) age 58.2 (10.02) years) in the patient education only group, and 22 patients (9 males/13 females, mean (SD) age 60.2 (9.49) years) in the patient education + exercise therapy group. Three-dimensional gait analysis was conducted at baseline and at four month follow-up. Sagittal and frontal plane joint angle displacement and external joint moments of the hip, knee and ankle were compared from a one-way analysis of covariance between the groups at follow-up, with baseline values as covariates (p < 0.05). No group differences were observed at the four-month follow-up in gait velocity, joint angle displacement, or moments. As the compliance in the exercise therapy group was inadequate, we calculated possible associations between the number of completed exercise sessions and change in each of the kinematic or kinetic variables. Associations were weak to neglible. Thus, the negative findings in this study cannot be explained from inadequate compliance alone, but most likely also suggest the exercise therapy program itself to be insufficient to engender gait alterations.</p><p><strong>Conclusions: </strong>Adding a 12-week supervised exercise therapy program to patient education did not induce changes in our selected biomechanical variables during the stance phase of gait, even when adjusting for poor compliance. Thus, we did not find evidence to support our exercise therapy program to be an efficacious intervention to induce gait alterations in this population of hip osteoarthritis patients.</p><p><strong>Trial registration: </strong>NCT00319423 at ClinicalTrials.gov (registration date 2006-04-26).</p>","PeriodicalId":73849,"journal":{"name":"Journal of negative results in biomedicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12952-015-0023-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33227378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
The 4-aminopiperidine series has limited anti-tubercular and anti-staphylococcus aureus activity. 4-氨基哌啶系列具有有限的抗结核和抗金黄色葡萄球菌活性。
Pub Date : 2015-02-13 DOI: 10.1186/s12952-015-0024-x
N Susantha Chandrasekera, Torey Alling, Mai Bailey, Aaron Korkegian, James Ahn, Yulia Ovechkina, Joshua Odingo, Tanya Parish

Background: Tuberculosis (TB) caused by Mycobacterium tuberculosis is the leading cause of death from a bacterial infection. The 4-aminopiperidine (PIP) series has been reported as having anti-bacterial activity against M. tuberculosis. We explored this series for its potential to inhibit aerobic growth of M. tuberculosis. We examined substitution at the N-1 position and C-4 position of the piperidine and modifications of the piperidine moiety systematically to delineate structure-activity relationships influencing potency. Compounds were tested for growth-inhibitory activity against virulent M. tuberculosis. A selected set of compounds were also tested for its activity against Staphylococcus aureus.

Results: The compound with a norbornenylmethyl substituent at the N-1 position and N-benzyl-N-phenethylamine at the C-4 position of the piperidine (1) was the only active compound with a minimum inhibitory concentration (MIC) of 10 μM against M. tuberculosis. Compounds were not active against S. aureus.

Conclusions: We were unable to derive any other analogs with MIC < 20 μM against M. tuberculosis. Therefore we conclude that the lack of activity is a liability in this series precluding it from further development.

背景:结核分枝杆菌引起的结核病(TB)是细菌感染导致死亡的主要原因。据报道,4-氨基哌啶(PIP)系列对结核分枝杆菌具有抗菌活性。我们探索了这个系列的潜力,以抑制结核分枝杆菌的有氧生长。我们系统地研究了哌啶在N-1位和C-4位的取代以及哌啶部分的修饰,以描述影响药效的构效关系。测定了化合物对致病性结核分枝杆菌的生长抑制活性。一组选定的化合物也测试了其对金黄色葡萄球菌的活性。结果:在哌替啶(1)的N-1位含有降冰片甲基取代基,C-4位含有n -苄基- n -苯乙胺的化合物是唯一对结核分枝杆菌具有10 μM最小抑制浓度(MIC)的活性化合物。化合物对金黄色葡萄球菌无活性。结论:我们无法获得任何其他MIC < 20 μM的抗结核分枝杆菌类似物。因此,我们得出结论,缺乏活动是该系列的一个不利因素,使其无法进一步发展。
{"title":"The 4-aminopiperidine series has limited anti-tubercular and anti-staphylococcus aureus activity.","authors":"N Susantha Chandrasekera,&nbsp;Torey Alling,&nbsp;Mai Bailey,&nbsp;Aaron Korkegian,&nbsp;James Ahn,&nbsp;Yulia Ovechkina,&nbsp;Joshua Odingo,&nbsp;Tanya Parish","doi":"10.1186/s12952-015-0024-x","DOIUrl":"https://doi.org/10.1186/s12952-015-0024-x","url":null,"abstract":"<p><strong>Background: </strong>Tuberculosis (TB) caused by Mycobacterium tuberculosis is the leading cause of death from a bacterial infection. The 4-aminopiperidine (PIP) series has been reported as having anti-bacterial activity against M. tuberculosis. We explored this series for its potential to inhibit aerobic growth of M. tuberculosis. We examined substitution at the N-1 position and C-4 position of the piperidine and modifications of the piperidine moiety systematically to delineate structure-activity relationships influencing potency. Compounds were tested for growth-inhibitory activity against virulent M. tuberculosis. A selected set of compounds were also tested for its activity against Staphylococcus aureus.</p><p><strong>Results: </strong>The compound with a norbornenylmethyl substituent at the N-1 position and N-benzyl-N-phenethylamine at the C-4 position of the piperidine (1) was the only active compound with a minimum inhibitory concentration (MIC) of 10 μM against M. tuberculosis. Compounds were not active against S. aureus.</p><p><strong>Conclusions: </strong>We were unable to derive any other analogs with MIC < 20 μM against M. tuberculosis. Therefore we conclude that the lack of activity is a liability in this series precluding it from further development.</p>","PeriodicalId":73849,"journal":{"name":"Journal of negative results in biomedicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12952-015-0024-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33104428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Interference with protease-activated receptor 1 does not reduce damage to subventricular zone cells of immature rodent brain following exposure to blood or blood plasma. 干扰蛋白酶活化受体 1 并不能减少未成熟啮齿动物脑室下区细胞暴露于血液或血浆后受到的损伤。
Pub Date : 2015-02-04 DOI: 10.1186/s12952-014-0022-4
Xiaoyan Mao, Marc R Del Bigio

Background: Prior work showed that whole blood, plasma, and serum injections are damaging to the neonatal rodent brain in a model of intracerebral/periventricular hemorrhage. Thrombin alone is also damaging. In adult animal models of hemorrhagic stroke, the protease-activated (thrombin) receptor PAR1 mediates some of the brain damage. We hypothesized that PAR1 interference will reduce the adverse effects of blood products on immature rodent brain and cells.

Results: Cultured oligodendrocyte precursor cells from rats and mice were exposed to blood plasma with and without the PAR1 antagonists SCH-79797 or BMS-200261. In concentrations previously shown to have activity on brain cells, neither drug showed evidence of protection against the toxicity of blood plasma. Newborn mice (wild type, heterozygous, and PAR1 knockout) were subjected to intracerebral injection of autologous whole blood into the periventricular region of the frontal lobe. Cell proliferation, measured by Ki67 immunoreactivity in the subventricular zone, was suppressed at 1 and 2 days, and was not normalized in the knockout mice. Cell apoptosis, measured by activated caspase 3 immunoreactivity, was not apparent in the subventricular zone. Increased apoptosis in periventricular striatal cells was not normalized in the knockout mice.

Conclusion: Interference with the thrombin-PAR1 system does not reduce the adverse effects of blood on germinal cells of the immature rodent brain. PAR1 interference is unlikely to be a useful treatment for reducing the brain damage that accompanies periventricular (germinal matrix) hemorrhage, a common complication of premature birth.

背景:先前的研究表明,在脑内/脑室周围出血模型中,注射全血、血浆和血清会对新生啮齿动物的大脑造成损害。单独注射凝血酶也会造成损害。在出血性中风的成年动物模型中,蛋白酶激活(凝血酶)受体 PAR1 会介导部分脑损伤。我们假设,PAR1干扰将减少血液制品对未成熟啮齿动物大脑和细胞的不利影响:结果:将培养的大鼠和小鼠少突胶质前体细胞暴露于含有或不含 PAR1 拮抗剂 SCH-79797 或 BMS-200261 的血浆中。在先前已证明对脑细胞具有活性的浓度下,这两种药物都没有显示出对血浆毒性的保护作用。新生小鼠(野生型、杂合子型和 PAR1 基因敲除型)脑内注射自体全血到额叶脑室周围区域。用室管膜下区的 Ki67 免疫反应测量细胞增殖,结果显示,1 天和 2 天后,PAR1 基因敲除小鼠的细胞增殖受到抑制,而且没有恢复正常。根据活化的 Caspase 3 免疫反应测定的细胞凋亡在脑室下区并不明显。脑室周围纹状体细胞凋亡的增加在基因敲除小鼠中没有恢复正常:结论:干扰凝血酶-PAR1系统并不能减少血液对未成熟啮齿类动物大脑生殖细胞的不利影响。PAR1干扰不可能成为减少脑室周围(胚芽基质)出血(早产的常见并发症)对大脑损伤的有效治疗方法。
{"title":"Interference with protease-activated receptor 1 does not reduce damage to subventricular zone cells of immature rodent brain following exposure to blood or blood plasma.","authors":"Xiaoyan Mao, Marc R Del Bigio","doi":"10.1186/s12952-014-0022-4","DOIUrl":"10.1186/s12952-014-0022-4","url":null,"abstract":"<p><strong>Background: </strong>Prior work showed that whole blood, plasma, and serum injections are damaging to the neonatal rodent brain in a model of intracerebral/periventricular hemorrhage. Thrombin alone is also damaging. In adult animal models of hemorrhagic stroke, the protease-activated (thrombin) receptor PAR1 mediates some of the brain damage. We hypothesized that PAR1 interference will reduce the adverse effects of blood products on immature rodent brain and cells.</p><p><strong>Results: </strong>Cultured oligodendrocyte precursor cells from rats and mice were exposed to blood plasma with and without the PAR1 antagonists SCH-79797 or BMS-200261. In concentrations previously shown to have activity on brain cells, neither drug showed evidence of protection against the toxicity of blood plasma. Newborn mice (wild type, heterozygous, and PAR1 knockout) were subjected to intracerebral injection of autologous whole blood into the periventricular region of the frontal lobe. Cell proliferation, measured by Ki67 immunoreactivity in the subventricular zone, was suppressed at 1 and 2 days, and was not normalized in the knockout mice. Cell apoptosis, measured by activated caspase 3 immunoreactivity, was not apparent in the subventricular zone. Increased apoptosis in periventricular striatal cells was not normalized in the knockout mice.</p><p><strong>Conclusion: </strong>Interference with the thrombin-PAR1 system does not reduce the adverse effects of blood on germinal cells of the immature rodent brain. PAR1 interference is unlikely to be a useful treatment for reducing the brain damage that accompanies periventricular (germinal matrix) hemorrhage, a common complication of premature birth.</p>","PeriodicalId":73849,"journal":{"name":"Journal of negative results in biomedicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33027744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chitosan-based scaffold modified with D-(+) raffinose for cartilage repair: an in vivo study. D-(+)棉子糖修饰壳聚糖基支架用于软骨修复的体内研究。
Pub Date : 2015-01-14 DOI: 10.1186/s12952-014-0021-5
Francesca Ravanetti, Carlo Galli, Edoardo Manfredi, Anna Maria Cantoni, Edoardo Scarpa, Guido Maria Macaluso, Antonio Cacchioli

Background: Osteochondral defects significantly affect patients' quality of life and represent challenging tissue lesions, because of the poor regenerative capacity of cartilage. Tissue engineering has long sought to promote cartilage repair, by employing artificial scaffolds to enhance cell capacity to deposit new cartilage. An ideal biomaterial should closely mimic the natural environment of the tissue, to promote scaffold colonization, cell differentiation and the maintenance of a differentiated cellular phenotype. The present study evaluated chitosan scaffolds enriched with D-(+) raffinose in osteochondral defects in rabbits. Cartilage defects were created in distal femurs, both on the condyle and on the trochlea, and were left untreated or received a chitosan scaffold. The animals were sacrificed after 2 or 4 weeks, and samples were analysed microscopically.

Results: The retrieved implants were surrounded by a fibrous capsule and contained a noticeable inflammatory infiltrate. No hyaline cartilage was formed in the defects. Although defect closure reached approximately 100% in the control group after 4 weeks, defects did not completely heal when filled with chitosan. In these samples, the lesion contained granulation tissue at 2 weeks, which was then replaced by fibrous connective tissue by week 4. Noteworthy, chitosan never appeared to be integrated in the surrounding cartilage.

Conclusions: In conclusion, the present study highlights the limits of D-(+) raffinose-enriched chitosan for cartilage regeneration and offers useful information for further development of this material for tissue repair.

背景:由于软骨再生能力差,骨软骨缺损严重影响患者的生活质量,是一种具有挑战性的组织病变。组织工程长期以来一直寻求通过使用人工支架来增强细胞沉积新软骨的能力来促进软骨修复。理想的生物材料应与组织的自然环境接近,以促进支架定植、细胞分化和维持分化的细胞表型。本研究对壳聚糖在兔骨软骨缺损中的应用进行了评价。在股骨远端,髁状突和滑车上都有软骨缺损,不进行治疗或接受壳聚糖支架。2周或4周后处死动物,显微镜下分析样品。结果:植入物被纤维囊包围,有明显的炎症浸润。缺损处未形成透明软骨。虽然4周后,对照组的缺损愈合率达到100%左右,但壳聚糖填充后缺损并没有完全愈合。在这些样本中,病变在2周时含有肉芽组织,然后在第4周被纤维结缔组织所取代。值得注意的是,壳聚糖从未与周围软骨融合。结论:本研究强调了D-(+)棉子糖壳聚糖用于软骨再生的局限性,为进一步开发这种组织修复材料提供了有益的信息。
{"title":"Chitosan-based scaffold modified with D-(+) raffinose for cartilage repair: an in vivo study.","authors":"Francesca Ravanetti,&nbsp;Carlo Galli,&nbsp;Edoardo Manfredi,&nbsp;Anna Maria Cantoni,&nbsp;Edoardo Scarpa,&nbsp;Guido Maria Macaluso,&nbsp;Antonio Cacchioli","doi":"10.1186/s12952-014-0021-5","DOIUrl":"https://doi.org/10.1186/s12952-014-0021-5","url":null,"abstract":"<p><strong>Background: </strong>Osteochondral defects significantly affect patients' quality of life and represent challenging tissue lesions, because of the poor regenerative capacity of cartilage. Tissue engineering has long sought to promote cartilage repair, by employing artificial scaffolds to enhance cell capacity to deposit new cartilage. An ideal biomaterial should closely mimic the natural environment of the tissue, to promote scaffold colonization, cell differentiation and the maintenance of a differentiated cellular phenotype. The present study evaluated chitosan scaffolds enriched with D-(+) raffinose in osteochondral defects in rabbits. Cartilage defects were created in distal femurs, both on the condyle and on the trochlea, and were left untreated or received a chitosan scaffold. The animals were sacrificed after 2 or 4 weeks, and samples were analysed microscopically.</p><p><strong>Results: </strong>The retrieved implants were surrounded by a fibrous capsule and contained a noticeable inflammatory infiltrate. No hyaline cartilage was formed in the defects. Although defect closure reached approximately 100% in the control group after 4 weeks, defects did not completely heal when filled with chitosan. In these samples, the lesion contained granulation tissue at 2 weeks, which was then replaced by fibrous connective tissue by week 4. Noteworthy, chitosan never appeared to be integrated in the surrounding cartilage.</p><p><strong>Conclusions: </strong>In conclusion, the present study highlights the limits of D-(+) raffinose-enriched chitosan for cartilage regeneration and offers useful information for further development of this material for tissue repair.</p>","PeriodicalId":73849,"journal":{"name":"Journal of negative results in biomedicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12952-014-0021-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32973019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
The high-affinity human IgG receptor Fc gamma receptor I (FcγRI) is not associated with vascular leakage of dengue. 高亲和力人IgG受体Fcγ受体I (Fcγ ri)与登革热血管渗漏无关。
Pub Date : 2015-01-08 DOI: 10.1186/s12952-014-0020-6
Zaiharina Mohamad Zamberi, Zuraihan Zakaria, Abu Thalhah Abdul Aziz, Benedict Sim Lim Heng, Masliza Zaid, Christopher Lee Kwok Chong, Fadzilah Mohd Noor, Sazaly Abu Bakar, Hoh Boon Peng

Background: Dengue is a major public health problem in many tropical and sub-tropical countries. Vascular leakage and shock are identified as the major causes of deaths in patients with severe dengue. Studies have suggested the potential role of Fc gamma receptors I (FcγRI) in the pathogenesis of dengue. We hypothesized that the circulating level of Fcγ receptor I could potentially be used as an indicator in assisting early diagnosis of severe dengue.

Results: A selected cohort of 66 dengue patients including 42 dengue with signs of vascular leakage, and 24 dengue without signs of vascular leakage were identified and were afterwards referred to as 'cases' and 'controls' respectively. Thirty seven normal healthy controls were also recruited in this study. The circulating level of FcγRI was quantified from the serum using enzyme-link immunosorbent assay (ELISA). The levels of FcγRI in both groups of patients with and without vascular leakage were found to be significantly higher than the normal healthy controls (P < 0.001). However, there was no significant difference found between patients with vascular leakage and those without vascular leakage (p = 0.777).

Conclusion: We suggest that FcγRI is not associated with the vascular leakage in dengue. However, further studies are necessary to delineate the role of FcγRI in antibody-dependent enhancement (ADE) mechanism.

背景:登革热是许多热带和亚热带国家的主要公共卫生问题。血管渗漏和休克被确定为重症登革热患者死亡的主要原因。研究表明Fcγ受体I (Fcγ ri)在登革热发病机制中的潜在作用。我们假设循环中Fcγ受体I的水平可能被用作协助重症登革热早期诊断的一个指标。结果:选出66名登革热患者,包括42名有血管渗漏迹象的登革热患者和24名没有血管渗漏迹象的登革热患者,随后分别被称为“病例”和“对照组”。本研究还招募了37名正常健康对照者。采用酶联免疫吸附法(ELISA)测定血清中fc - γ - ri的循环水平。两组有和无血管渗漏患者的fc γ - ri水平均显著高于正常健康对照组(P < 0.001)。而有血管渗漏的患者与无血管渗漏的患者无统计学差异(p = 0.777)。结论:fc γ - ri与登革热患者血管渗漏无关。然而,需要进一步研究fc γ - ri在抗体依赖性增强(ADE)机制中的作用。
{"title":"The high-affinity human IgG receptor Fc gamma receptor I (FcγRI) is not associated with vascular leakage of dengue.","authors":"Zaiharina Mohamad Zamberi,&nbsp;Zuraihan Zakaria,&nbsp;Abu Thalhah Abdul Aziz,&nbsp;Benedict Sim Lim Heng,&nbsp;Masliza Zaid,&nbsp;Christopher Lee Kwok Chong,&nbsp;Fadzilah Mohd Noor,&nbsp;Sazaly Abu Bakar,&nbsp;Hoh Boon Peng","doi":"10.1186/s12952-014-0020-6","DOIUrl":"https://doi.org/10.1186/s12952-014-0020-6","url":null,"abstract":"<p><strong>Background: </strong>Dengue is a major public health problem in many tropical and sub-tropical countries. Vascular leakage and shock are identified as the major causes of deaths in patients with severe dengue. Studies have suggested the potential role of Fc gamma receptors I (FcγRI) in the pathogenesis of dengue. We hypothesized that the circulating level of Fcγ receptor I could potentially be used as an indicator in assisting early diagnosis of severe dengue.</p><p><strong>Results: </strong>A selected cohort of 66 dengue patients including 42 dengue with signs of vascular leakage, and 24 dengue without signs of vascular leakage were identified and were afterwards referred to as 'cases' and 'controls' respectively. Thirty seven normal healthy controls were also recruited in this study. The circulating level of FcγRI was quantified from the serum using enzyme-link immunosorbent assay (ELISA). The levels of FcγRI in both groups of patients with and without vascular leakage were found to be significantly higher than the normal healthy controls (P < 0.001). However, there was no significant difference found between patients with vascular leakage and those without vascular leakage (p = 0.777).</p><p><strong>Conclusion: </strong>We suggest that FcγRI is not associated with the vascular leakage in dengue. However, further studies are necessary to delineate the role of FcγRI in antibody-dependent enhancement (ADE) mechanism.</p>","PeriodicalId":73849,"journal":{"name":"Journal of negative results in biomedicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12952-014-0020-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32956763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
期刊
Journal of negative results in biomedicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1